Skip to main content
Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.770
+0.140 (8.59%)
Nov 21, 2024, 3:39 PM EST - Market open

Iterum Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
40.19M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 201937.00K-832.00K-95.74%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 180.02M
HOOKIPA Pharma 50.00M
DURECT 8.59M
Co-Diagnostics 7.32M
Moolec Science 5.63M
Eterna Therapeutics 598.00K
Revenue Rankings

ITRM News

More News